Who is sponsoring NCT06138938?

NCT06138938 is sponsored by Istanbul Medeniyet University.

What drugs are being tested in NCT06138938?

Interventions in NCT06138938: Intraoperative abdominal irrigation.

What condition does NCT06138938 study?

NCT06138938 studies Cesarean Section, Visual Analog Scale.

Is NCT06138938 still recruiting?

NCT06138938 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT06138938

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Abdominal Irrigation During Cesarean

Completed NA Last updated 18 November 2023

What this trial tests

NA trial testing Intraoperative abdominal irrigation in Cesarean Section in 60 participants. Completed in 30 June 2022.

Timeline

1 March 2022

Primary endpoint
31 May 2022

30 June 2022

Quick facts

Lead sponsor	Istanbul Medeniyet University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	60
Start date	1 March 2022
Primary completion	31 May 2022
Estimated completion	30 June 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Intraoperative abdominal irrigation

Conditions studied

Cesarean Section — all drugs for Cesarean Section →
Visual Analog Scale — all drugs for Visual Analog Scale →

Sponsor

Istanbul Medeniyet University

Who can join

Adults 18 to 45, female only, with Cesarean Section or Visual Analog Scale. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective randomized controlled clinical trial was conducted between March 2022 and May 2022 and included 60 patients who underwent elective cesarean. The participants were randomized into two groups: abdominal irrigation (n=30) and control group (n=30). Participants undergo a standard cesarean procedure, and general anesthesia was preferred. The patients were questioned regarding nausea, vomiting, highest pain scores, time of flatus, and stool passage during the postoperative period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Erratum.
· 2023 · PMID 38148729 · DOI 10.4274/mmj.galenos.2023.e002

Verify or expand the search:

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07440667 — Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section · NA · recruiting

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06138938 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06138938.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing